Acetaminophen induces mitochondrial apoptosis through proteasome dysfunctions.

Area of Science:

• Biochemistry
• Cell Biology
• Pharmacology

Background:

• Acetaminophen is a common analgesic and antipyretic.
• Emerging research suggests acetaminophen has anti-proliferative effects and can induce apoptosis.
• The precise molecular mechanisms underlying acetaminophen's anti-cancer potential remain unclear.

Purpose of the Study:

• To investigate the molecular mechanisms of acetaminophen's anti-proliferative effects.
• To explore acetaminophen's impact on proteasomal function and cellular apoptosis.
• To determine if acetaminophen can be a basis for developing novel anti-cancer therapeutics.

Main Methods:

• In-silico analysis to predict acetaminophen-proteasome interaction.
• Cellular treatment with acetaminophen.
• Assessment of proteasome activity, protein aggregation, and mitochondrial morphology.
• Analysis of apoptosis markers and morphological changes.

Main Results:

• Acetaminophen treatment led to proteasomal dysfunction and accumulation of ubiquitylated proteins.
• Observed mitochondrial abnormalities and pro-apoptotic morphological changes.
• Confirmed depletion of proteasome activity and induction of cell apoptosis.

Conclusions:

• Acetaminophen induces apoptosis through proteasomal dysfunction and mitochondrial abnormalities.
• Acetaminophen exhibits promising anti-proliferative effects.
• Findings support developing acetaminophen-based proteasome inhibitors for cancer therapy, potentially enhancing other anti-tumor drugs.